Furthermore, high serum levels of IL-17 and IL-2, as well as low levels of IL-4 and IL-10, appear to constitute a long COVID-19 cytokine profile (molecular signature), and identification of these markers as a potential target may establish more adequate treatment and prevention strategies for specific groups. This evidence concerns the gene IL4 and COVID-19.